“A Prospective Observational Study of Comparison, Safety, and Efficacy of Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes Mellitus in A Tertiary Care Hospital”, AJPHS, vol. 12, no. 4, pp. 2729–2738, Dec. 2022, doi: 10.5530/ezagjy22.